SeoulMarkets · tag
dilution
5 stories tagged “dilution”, each from official Korean data with its source and timestamp.
EcoPro BM's ₩886bn raise: 100% for an unnamed acquisition
EcoPro BM's rights issue creates 9,900,990 new shares at ₩89,500 — a 16% discount to the ₩106,500 close — diluting existing holders 9.2%. All ₩886.1bn raised is filed as 'business acquisition'; no target has been separately disclosed.
From Celltrion to KG Mobility, one flaw repeats
This week we ranked 35 Korean capital-raising filings three ways — buybacks, rights issues, convertible bonds. In every single one, the size of the deal did not predict what it meant for existing shareholders.
KG Mobility's convertible bond dilutes shares 22%
Five Korean convertible bonds filed this week all pay 0% surface interest — the option to convert is the entire return. Potential dilution on conversion ranges from 1.0% to 22.0%, and it isn't the biggest raise that dilutes least.
Samsung Biologics raised 300x more, diluted 11x less
Samsung Biologics' ₩3.00tn rights issue diluted shareholders 4.7%. PhionX raised 300 times less — and diluted 53.8%, eleven times more. Twenty-one filings this week show size doesn't predict dilution.
Korea's convertibles create new shares at a 24% discount. Cash raises, 12%.
Measured against the market price on the day the shares are created, convertibles dilute at a 23.8% discount and cash raises at 12.5%. Control for the 456 companies that used both and the convertible still discounts 7.7 points deeper.